Damon Silvestry's most recent trade in Biora Therapeutics Inc was a trade of 4,566 Common Stock done at an average price of $3.5 . Disclosure was reported to the exchange on Nov. 15, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biora Therapeutics Inc | Damon Silvestry | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.47 per share. | 15 Nov 2021 | 4,566 | 291,499 | - | 3.5 | 15,844 | Common Stock |
| Biora Therapeutics Inc | Damon Silvestry | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. | 15 Aug 2021 | 1,478 | 289,178 | - | 1.7 | 2,453 | Common Stock |
| Biora Therapeutics Inc | Damon Silvestry | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 118,810 | 118,810 | - | - | Stock Option (Right to Buy) | |
| Biora Therapeutics Inc | Damon Silvestry | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 73,107 | 294,337 | - | 0 | Common Stock | |
| Biora Therapeutics Inc | Damon Silvestry | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.41 per share. | 15 Apr 2021 | 3,681 | 290,656 | - | 3.4 | 12,552 | Common Stock |
| Biora Therapeutics Inc | Damon Silvestry | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2021 | 13,431 | 13,431 | - | - | Stock Option (Right to Buy) |